Clearstead Advisors’s Nu Skin NUS Stock Holding History

Clearstead Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9	Closed	-$87	–	2660
2025 Q4	$87	Sell	9 -37	-80%	-$383	﹤0.01%	2538
2025 Q3	$561	Buy	+46	New	+$483	﹤0.01%	2719

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Clearstead Advisors's NUS Position: Q1 2026 in Review

Clearstead Advisors sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 9 shares — an estimated $87 sold.

Clearstead Advisors first reported a position in NUS in Q3 2025 and held it in 2 quarters. The position peaked at $561 in Q3 2025. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

Clearstead Advisors reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
Clearstead Advisors sold 9 Nu Skin shares in Q1 2026, an estimated $87.
Clearstead Advisors first reported a position in Nu Skin in Q3 2025 and held it in 2 quarters.
Clearstead Advisors's Nu Skin position peaked at $561 in Q3 2025.
178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.